The BRAGGSS Study collects data from patients receiving biologic therapy to evaluate the role of genetic variation, psychological status, clinical variables, serological measures and environmental factors in determining response to treatment.
This website is for researchers only. If you are a participant and would like some more information please contact:
Sarah Ashton, Study Coordinator
sarah.ashton-2@manchester.ac.uk
Tel: 0161 306 0539
Zahra Arain, Project Assistant (Mondays and Tuesdays)
zahra.arain@manchester.ac.uk
Tel: 0161 275 7146